Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

NCT: NCT04248283 · RECRUITING

NCT IDNCT04248283
StatusRECRUITING
Start Date2021-01-26
Completion2032-05-31
SponsorUromedica (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.

Frequently Asked Questions

What is Adjustable Continence Therapy (ACT) for the Treatment of Female SUI?

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI is a clinical trial registered under NCT04248283. Current status: RECRUITING.

What is the status of NCT04248283?

The current status of NCT04248283 (Adjustable Continence Therapy (ACT) for the Treatment of Female SUI) is: RECRUITING.

When did Adjustable Continence Therapy (ACT) for the Treatment of Female SUI start?

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI started on 2021-01-26.

Related Devices

PMA P130018Device, incontinence, mechanical/hydraulicUromedica, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑